BackgroundIn this double-blinded randomized clinical trial, we aimed to compare safety and efficacy of combination of dexmedetomidine and ketamine (DK) with propofol and fentanyl (PF) for sedation in colonoscopy patients.MethodsIn this study, 64 patients undergoing colonoscopy were randomized in two groups, A, receiving PF, and B receiving DK for sedation. Among 64 patients, 31 patients included in PF and 33 patients included in DK group. Both groups were similar in terms of demographics. Patients’ sedation score (based on Ramsy scale) and vital signs recorded at the times of 2, 5, 10 and 15 minutes. Complications including apnea, hypotension, hypoxia, nausea and vomiting along with gastroenterologist satisfaction and patients’ pain score (based on Wong Baker faces pain assessment scale) recorded by a checklist. Data were analyzed by SPSS V.18, using chi-square, independent t-tests and repeated measure analysis with a p value < 0.05 significance level.ResultsThe mean score of sedation was 4.82 ± 0.49 in DK group and 5.22 ± 0.45 in PF group (p value = 0.001). Serious complications, including hypotension (p value = 0.005) and apnea (p value = 0.10) were significantly higher in PF group. Satisfaction of gastroenterologist (p value = 0.400) and patients’ pain score (p value = 0.900) were similar among groups.ConclusionCombination of DK provides sufficient sedation with less complications in compare with PF in colonoscopy patients.Trial registrationThe study protocol designed on the basis of Helsinki declaration for ethical consideration and was approved by the Ethics Committee of Qom University of Medical Sciences (ethics code: IR.MUQ.REC.1397.149); the study was also registered at the Iranian Center for Clinical Trials (No. IRCT20161205031252N11).